Video

Impurity Isolation and Identification

In his presentation from IVT's 9th Annual Method Validation and Development conference, Rafail Usatinsky explains how to isolate and identify impurities in the drug development timeline. Ustatinksy discusses what needs to be determined in the initial planning and compares the concepts of isolation versus synthesis. Usatinsky also illustrated the proper methodology with an impurity isolation case study.

Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.

Comments (0)

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.
Image CAPTCHA
Enter the characters shown in the image.